Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Childhood hearing loss detected beyond the newborn screen (2023) |
Auteurs : | E. Jane Fitzgibbons, Auteur ; Stephanie Keszegi, Auteur ; Carlie Driscoll, Auteur ; Raphael Beswick, Auteur |
Type de document : | Article |
Dans : | International Journal of Audiology IJA (Vol. 62, n° 3, Mars 2023) |
Article en page(s) : | p. 278-285 |
Note générale : | https://doi-org.ezproxy.vinci.be/10.1080/14992027.2022.2042606 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Dépistage auditif du nouveau-né ; Facteurs de risque ; Nouveau-né ; Perte d'audition ; Surveillance |
Résumé : |
Objective
To understand the characteristics of postnatal hearing loss (PNHL) identified via different referral pathways, to inform childhood hearing screening and referral practices. Design Retrospective analysis of screening and audiology records. Study sample A cohort of 385 children who passed newborn hearing screening in Queensland, Australia between September 2004 and December 2017 and were later diagnosed with permanent hearing loss. Results Neonatally identified risk factors facilitated detection for half the cohort, with PNHL detected earlier (average age of 31 months) and at a milder degree. PNHL was detected at an average age of 49 months via other pathways. Proportions of bilateral moderate or greater PNHL were greatest in children with significant medical circumstances (60.7%) and those with noted delays or concerns (39.2%), whereas childhood hearing screening programs detected greater proportions of unilateral moderate or greater PNHL (47.4%). Conclusions Risk-factor-based surveillance detects PNHL early but does not detect all cases. Screening children with speech and language delays, parental or professional concern, or with relevant medical circumstances (eg meningitis or chemotherapy) is warranted based on the types of PNHL detected. Further evidence may be required to justify the rollout of postnatal population childhood screening programs. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.tandfonline.com/doi/full/10.1080/14992027.2022.2042606 |